Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Rheos Medicines is a biopharmaceutical company developing novel medicines that modulate immune cell metabolism with an initial focus on treating patients with severe autoimmune diseases and cancer. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function. We have brought together leading scientists whose ...
Rheos Medicines is a biopharmaceutical company developing novel medicines that modulate immune cell metabolism with an initial focus on treating patients with severe autoimmune diseases and cancer. We are rapidly applying a first-in-field approach in immunometabolism with a comprehensive, systems-biology understanding of the metabolic pathways that drive immune cell function. We have brought together leading scientists whose discoveries opened the field of immunometabolism, clinicians with a deep understanding of the heterogeneity of immune-mediated diseases, and an experienced leadership team.

List your booth number for exhibitions, ask us